FOLD logo

FOLD
Amicus Therapeutics Inc

6,370
Mkt Cap
$4.53B
Volume
573.00
52W High
$14.46
52W Low
$5.51
PE Ratio
-162.98
FOLD Fundamentals
Price
$14.44
Prev Close
$14.46
Open
$14.46
50D MA
$14.35
Beta
0.80
Avg. Volume
3.78M
EPS (Annual)
-$0.0879
P/B
16.37
Rev/Employee
$1.24M
$4,539.93
Loading...
Loading...
News
all
press releases
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year High - Still a Buy?
Amicus Therapeutics (NASDAQ:FOLD) Hits New 12-Month High - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
210,800 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by CIBRA Capital Ltd
CIBRA Capital Ltd bought a new stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·4d ago
News Placeholder
Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?
Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·6d ago
News Placeholder
Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·7d ago
News Placeholder
JPMorgan Chase & Co. Sells 94,105 Shares of Amicus Therapeutics, Inc. $FOLD
JPMorgan Chase & Co. reduced its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 4.3% during the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·8d ago
News Placeholder
Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week High - What's Next?
Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year High - What's Next...
MarketBeat·10d ago
News Placeholder
Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week High - Time to Buy?
Amicus Therapeutics (NASDAQ:FOLD) Sets New 1-Year High - Should You Buy...
MarketBeat·16d ago
News Placeholder
872,411 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Ion Asset Management Ltd.
Ion Asset Management Ltd. purchased a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the third quarter, according to the company in its most recent disclosure...
MarketBeat·17d ago
News Placeholder
Iron Triangle Partners LP Takes Position in Amicus Therapeutics, Inc. $FOLD
Iron Triangle Partners LP purchased a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·17d ago
<
1
2
...
>

Latest FOLD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.